Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bradley Giedd

Optometrist Winter Park, FL Doctor of Optometry

NPI 1679551444 CMS profile 303222

1928 Howell Branch Rd, Winter Park, FL 32792

Open in the dashboard

General payments

$187,621

446 records reported · program years 2019–2025

Research payments

$2,347,444

Paid to them · 3,304 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,313,832 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Bradley Giedd of Winter Park, FL is reported in the CMS Open Payments database as having received $187,621 across 446 general payments and $2,347,444 in research payments paid to them. Separately, studies naming them as principal investigator received $2,313,832 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $35,778 78
2025 Research $198,907 241
2024 General $26,917 80
2024 Research $236,227 229
2023 General $46,617 109
2023 Research $221,173 295
2022 General $31,290 71
2022 Research $421,319 528
2021 General $13,963 25
2021 Research $427,170 745
2020 General $11,915 34
2020 Research $563,789 821
2019 General $21,141 49
2019 Research $278,858 445

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradley Giedd
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Bradley Giedd were reported at $35,778. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Bradley Giedd Optometrist median Middle half National median
2019 $21,141 $159 $67–$371 $163
2020 $11,915 $72 $29–$165 $114
2021 $13,963 $125 $46–$292 $132
2022 $31,290 $162 $66–$374 $149
2023 $46,617 $177 $72–$406 $160
2024 $26,917 $188 $77–$427 $164
2025 $35,778 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Johnson & Johnson Vision Care, Inc. $151,931 366 payments
  2. Alcon Vision LLC $27,222 49 payments
  3. Alcon Research LLC $7,556 11 payments
  4. Bausch & Lomb Americas Inc. $519 8 payments
  5. Topcon Medical Systems, Inc. $164 1 payment
  6. Bausch & Lomb, a division of Bausch Health US, LLC $118 6 payments
  7. AbbVie, Inc. $29 1 payment
  8. Osmotica Pharmaceutical Corp. $23 1 payment
  9. Sun Pharmaceutical Industries Inc. $22 1 payment
  10. Tarsus Pharmaceuticals, Inc. $21 1 payment
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $110,233 72 payments
  2. Consulting Fee $40,469 29 payments
  3. Travel and Lodging $27,011 128 payments
  4. Food and Beverage $9,901 216 payments
  5. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. Acuvue $142,024 333 payments
  2. TOTAL30 $11,338 14 payments
  3. DAILIES TOTAL1 $5,672 14 payments
  4. DAILIES $4,674 9 payments
  5. Precision 1 $2,078 10 payments
  6. Systane Ophthalmology $2,063 8 payments
  7. Dailies Aqua Comfort Plus $1,813 6 payments
  8. Pataday $1,260 2 payments
  9. Systane Ophthalmology $1,260 1 payment
  10. INFUSE $377 7 payments
  11. Other $486 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Alcon Research LLC $2,347,444 3,304 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Optometry: 120

Drug cost

$252

Median for Optometry: $8,864

Branded share of claims

0%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Latanoprost Generic 12 $252

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$14,339

Medicare's payments for the services billed

Medicare patients

160

Average age 75

Services billed

210

93 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 38%
Ischemic heart disease 31%
Diabetes 21%
Chronic kidney disease 21%
Depression 19%
Atrial fibrillation 18%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Cequa
  • Sun Pharmaceutical Industries Inc. $22
$22 — —
MIEBO
  • Bausch & Lomb Americas Inc. $21
$21 — —
XIIDRA
  • Bausch & Lomb Americas Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

3,750 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record